The molecular properties that allow UBQLN2 to act as a negative regulator of SG formation, equally promote the clearance of aggregates in C9ORF72 and FUS models of ALS [20,24,32,78]. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.